Ghost Tree Capital, LLC Blueprint Medicines Corp Transaction History
Ghost Tree Capital, LLC
- $267 Million
- Q3 2024
A detailed history of Ghost Tree Capital, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 140,000 shares of BPMC stock, worth $12.6 Million. This represents 4.85% of its overall portfolio holdings.
Number of Shares
140,000
Previous 40,000
250.0%
Holding current value
$12.6 Million
Previous $4.31 Million
200.26%
% of portfolio
4.85%
Previous 1.76%
Shares
13 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$602 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$599 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$486 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$357 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$249 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.38B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...